Procter & Gamble (PG) Earnings Date & Reports

Key Takeaways

• Procter & Gamble reported fourth quarter fiscal 2026 net sales of $21.2 billion, up 2% year over year, while organic sales were flat versus the prior year.
• Core earnings per share (EPS) came in at $1.43, down 3% and slightly above the $1.41 consensus estimate; diluted EPS fell 15% to $1.26.
• Revenue of $21.20 billion missed the roughly $21.38 billion consensus, while core EPS narrowly beat expectations.
• Full-year fiscal 2026 net sales rose 3% to $87.0 billion, with core EPS up 1% to $6.89 and diluted EPS up 2% to $6.62.
• The company issued fiscal 2027 guidance that flags an approximately $1 billion after-tax cost headwind tied to raw materials, energy, and transportation.

Earnings Context and Why It Matters

Procter & Gamble is the world's largest consumer packaged goods company, with brands such as Tide, Pampers, Gillette, and Crest sold in roughly 70 countries. Its results are closely watched as a read on global consumer spending, pricing power, and cost management across the staples sector. This report closed out a fiscal year the company described as one of "foundation building" amid a challenging geopolitical and economic environment. Investors are particularly focused on how P&G balances reinvestment in marketing and innovation against rising commodity, energy, and tariff costs, and on whether its productivity program can protect margins into fiscal 2027.

Reported Results

For the fourth quarter of fiscal 2026 (April–June 2026), Procter & Gamble posted net sales of $21.2 billion, an increase of 2% versus the prior year. Organic sales, which exclude the effects of foreign exchange and acquisitions or divestitures, were unchanged. Diluted EPS was $1.26, down 15%, while core EPS, a non-GAAP (non-Generally Accepted Accounting Principles) measure that excludes restructuring and other one-time items, declined 3% to $1.43. Core EPS came in modestly above the consensus estimate of $1.41, whereas revenue slightly missed the approximately $21.38 billion analyst expectation.

For the full fiscal year, net sales grew 3% to $87.0 billion, organic sales rose 1%, diluted EPS increased 2% to $6.62, and core EPS increased 1% to $6.89. Operating cash flow reached $19.6 billion for the year, and the company returned more than $15 billion to shareholders through $10.2 billion in dividends and $5.0 billion in share repurchases.

Management issued fiscal 2027 guidance for all-in and organic sales growth of 1% to 3%, diluted EPS growth of 1% to 5%, and core EPS growth of in-line to 3% (a range of $6.89 to $7.11). This outlook includes an estimated $1 billion after-tax headwind from higher raw material, energy, and transportation costs, plus additional pressure from higher net interest expense.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters, including industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking consumer staples names like Procter & Gamble, the AI Screener can help identify comparable opportunities and monitor evolving technical conditions across the sector.

Market Reaction and Investor Sentiment

The modest core EPS beat was offset by a revenue miss and flat organic sales, leaving a mixed signal for investors. The more significant driver of sentiment was fiscal 2027 guidance, which highlighted roughly $0.56 per share of combined headwinds from commodities, interest expense, and foreign exchange. Management indicated these factors equate to an approximately eight percent drag on core EPS growth, suggesting margins may stay under pressure even as the company continues to invest in demand creation. Investors will weigh the durability of P&G's productivity savings and selective, innovation-led pricing against the risk of continued input-cost inflation and a cautious consumer.

Forward Outlook and Key Factors to Monitor

Looking ahead, the central question for Procter & Gamble is whether its productivity program and pricing strategy can offset a steep input-cost environment. The company expects to incur roughly $1 billion in after-tax cost headwinds in fiscal 2027, driven largely by raw materials, energy, and transportation, alongside higher net interest expense and unfavorable foreign exchange.

Investors should monitor several factors. First, organic sales growth is guided to only 1% to 3%, including a 30-to-50-basis-point headwind from brand and go-to-market discontinuations tied to its restructuring plan. Second, gross margin trends will be critical, as the company balances productivity savings against product mix, reinvestments, and commodity costs. Third, watch category-level momentum, particularly in Beauty and in Greater China, where SK-II and Baby Care have shown strength but where the consumer environment remains challenging.

Finally, cash generation and capital returns remain a key support. P&G expects adjusted free cash flow productivity of 85% to 90% and plans roughly $10 billion in dividends and $5 billion in buybacks for fiscal 2027, continuing a streak of 70 consecutive years of dividend increases. How effectively management converts productivity gains into margin protection will likely shape investor confidence through the next several quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations